As of 2025-07-17, the Fair Value of Fusion Pharmaceuticals Inc (FUSN) is -6.13 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 21.55 USD, the upside of Fusion Pharmaceuticals Inc is -128.44%.
With the market price of 21.55 USD and our fair value calculation, Fusion Pharmaceuticals Inc (FUSN) is not a good investment. Investing in FUSN stocks now will result in a potential loss of 128.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -16.19 | -78.33 | -81.05 | -87.61 | -94.90 | -71.62 |
| YoY growth | -38.97% | -383.82% | -3.47% | -8.09% | -8.32% | -88.53% |
| Market Cap (mil) | 1,833.04 |
| P/E | |
| Forward P/E |
| EPS | -1.23 |
| Avg earnings growth rate | -88.53% |
| TTM earnings | -104.28 |